What's Happening?
Levee Medical has announced that the American Medical Association's CPT Editorial Panel has approved a Category III CPT code for the placement of the Voro Urologic Scaffold during radical prostatectomy
procedures. This new code, effective July 1, 2026, marks a significant step towards obtaining reimbursement for the procedure. The Voro Urologic Scaffold is designed to support the bladder neck and preserve urethral length, aiding in the return to continence following prostate surgery. The device is currently being evaluated in the ARID II clinical trial, which aims to demonstrate its safety and effectiveness compared to traditional methods.
Why It's Important?
The approval of a Category III CPT code for the Voro Urologic Scaffold is a crucial milestone for Levee Medical, as it validates the technology and paves the way for future reimbursement. This development highlights the need for improved surgical options to manage stress urinary incontinence after prostate surgery, a common complication affecting many patients. The scaffold's innovative design could significantly enhance post-operative outcomes, potentially reducing healthcare costs associated with long-term management of incontinence. As the technology gains recognition, it may influence surgical practices and encourage further advancements in urologic care.
What's Next?
With the new CPT code in place, Levee Medical will focus on transitioning the procedure to a Category I CPT code, which would facilitate broader reimbursement and adoption. The ongoing ARID II clinical trial will provide essential data to support this transition, demonstrating the scaffold's effectiveness and safety. As the trial progresses, Levee Medical will likely engage with healthcare providers and payers to promote the technology and secure its place in standard prostate cancer treatment protocols. Successful integration of the Voro Urologic Scaffold into clinical practice could lead to improved patient outcomes and set a precedent for future innovations in surgical care.
